A Meta-Analysis of Randomized Controlled Trials Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Alone in HER-2-Positive Advanced Breast Cancer

被引：6
|
作者：
Liao, Cun [1 ]
Yin, Fang [1 ]
Huang, Ping [1 ]
Cao, Yunfei [1 ]
Gao, Feng [1 ]
机构：
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Colorectal & Anal Surg, Nanning, Guangxi, Peoples R China
来源：
BREAST JOURNAL | 2011年 / 17卷 / 01期
关键词：
PHASE-II TRIAL; PACLITAXEL; THERAPY;
D O I：
10.1111/j.1524-4741.2010.01034.x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：109 / 111
页数：3
相关论文
共 50 条
  • [21] Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Bonilla, Luisa
    Ben-Aharon, Irit
    Vidal, Liat
    Gafter-Gvili, Anat
    Leibovici, Leonard
    Stemmer, Salomon M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (24): : 1845 - 1854
  • [22] Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: A systematic review of randomized controlled trials
    Brollo, Janaina
    Curigliano, Giuseppe
    Disalvatore, Davide
    Marrone, Bianca Fontana
    Criscitiello, Carmen
    Bagnardi, Vincenzo
    Kneubil, Maximiliano Cassilha
    Fumagalli, Luca
    Locatelli, Marzia
    Manunta, Silvia
    Goldhirsch, Aron
    CANCER TREATMENT REVIEWS, 2013, 39 (01) : 44 - 50
  • [23] Bevacizumab combined with chemotherapy for glioblastoma: a meta-analysis of randomized controlled trials
    Yang, Shou-Bo
    Gao, Kai-Di
    Jiang, Tao
    Cheng, Shu-Jun
    Li, Wen-Bin
    ONCOTARGET, 2017, 8 (34) : 57337 - 57344
  • [24] Chemotherapy with or without irinotecan in patients with advanced or recurrent gastric cancer: a meta-analysis of randomized controlled trials
    Zeng Chao
    Zhou Hang
    Wei Yang
    Wang Liyang
    Xie Hua
    Yao Wenxiu
    CHINESE MEDICAL JOURNAL, 2014, 127 (05) : 951 - 956
  • [25] Efficacy analysis of trastuzumab, carboplatin and docetaxel in HER-2-positive breast cancer patients
    Wu, Di
    Xiong, Liangfa
    ONCOLOGY LETTERS, 2020, 19 (03) : 2539 - 2546
  • [26] Efficacy and safety of first-line therapy in patients with HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trials
    Wang, Junxiao
    Yu, Yushuai
    Lin, Qisheng
    Zhang, Jie
    Song, Chuangui
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (01)
  • [27] Efficacy and Cardiotoxicity of Liposomal Doxorubicin-Based Chemotherapy in Advanced Breast Cancer: A Meta-Analysis of Ten Randomized Controlled Trials
    Xing, Meiyuan
    Yan, Feifei
    Yu, Sufen
    Shen, Peng
    PLOS ONE, 2015, 10 (07):
  • [28] Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials
    Coccolini, F.
    Cotte, E.
    Glehen, O.
    Lotti, M.
    Poiasina, E.
    Catena, F.
    Yonemura, Y.
    Ansaloni, L.
    EJSO, 2014, 40 (01): : 12 - 26
  • [29] Effects of lapatinib or trastuzumab, alone and in combination, in human epidermal growth factor receptor 2-positive breast cancer: a meta-analysis of randomized controlled trials
    Xin, Yong
    Guo, Wen Wen
    Huang, Qian
    Zhang, Pei
    Zhang, Long-Zhen
    Jiang, Guan
    Tian, Ye
    CANCER MEDICINE, 2016, 5 (12): : 3454 - 3463
  • [30] Neoadjuvant chemotherapy and concomitant trastuzumab in breast cancer: a pooled analysis of two randomized trials
    Petrelli, Fausto
    Borgonovo, Karen
    Cabiddu, Mary
    Ghilardi, Mara
    Barni, Sandro
    ANTI-CANCER DRUGS, 2011, 22 (02) : 128 - 135
12345